Awardee OrganizationICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Description
Abstract Text
HIV-associated nephropathy (HIVAN) is now the third leading cause of renal failure in African
Americans, the most common cause of chronic renal failure in HIV-1 infected individuals and renal disease is now the fourth leading cause of death in these patients. Accumulating evidence supports a direct role of HIV-1 infection of renal glomerular and tubule epithelial cells in HIVAN pathogenesis. Furthermore, quasispecies analysis of HIV-1 envelope sequences simultaneously derived from renal epithelial cells and peripheral blood mononuclear cells show renal-specific subclusters consistent with active replication of HIV-1 in the renal compartment. In vitro and transgenic mouse model data suggest that direct expression of HIV-1 genes, particularly nef, in renal epithelium can produce phenotypic changes and alterations in expression of cell genes involved in proliferation and differentiation that are consistent with changes associated with HIVAN. Project 2 will further define the direct role of infection of renal epithelial cells in HIVAN pathogenesis. To determine if renal epithelial infection alone can account for the disease, renal tissue will be examined from HIV-infected patients who have an alternative etiology of renal disease. This will include those of African descent as well as Caucasians. Examination of tissue will include in situ DNA PCR and confirmatory laser dissection of epithelial cells with PCR amplification of HIV sequences. To further our understanding of viral lentry into this unique compartment, we will phenotypically characterize the HIV-1 envelopes directly obtained from renal epithelium by laser capture dissection. In light of our previous published work and preliminary data demonstrating the effects of Nef and, to a lesser degree, Vpr on podocytes, we will use transgeneic mouse modeling to study the contribution of individual gene products expressed in specific cell types to pathogenesis. Targeted expression will be achieved either through direct expression of the transgene from site-specific promoters or the use of conditional transgenic constructs. Furthermore, nef sequences derived directly from renal epithelium will be genotypically and phenotypically characterized to determine if unique polymorphisms are associated with the development of HIVAN. The proposed studies should provide critical
information regarding the role of epithelial infection in HIVAN pathogenesis and the interaction of HIV-1 with this unique reservoir and will impact on therapeutic interventions to prevent this devastating complication.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
078861598
UEI
C8H9CNG1VBD9
Project Start Date
01-July-2004
Project End Date
30-June-2009
Budget Start Date
01-July-2004
Budget End Date
30-June-2005
Project Funding Information for 2004
Total Funding
$318,048
Direct Costs
$187,639
Indirect Costs
$130,409
Year
Funding IC
FY Total Cost by IC
2004
National Institute of Diabetes and Digestive and Kidney Diseases
$318,048
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2P01DK056492-06 0002
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P01DK056492-06 0002
Patents
No Patents information available for 2P01DK056492-06 0002
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P01DK056492-06 0002
Clinical Studies
No Clinical Studies information available for 2P01DK056492-06 0002
News and More
Related News Releases
No news release information available for 2P01DK056492-06 0002
History
No Historical information available for 2P01DK056492-06 0002
Similar Projects
No Similar Projects information available for 2P01DK056492-06 0002